Lord Abbett Health Care Fund

Lord Abbett Health Care Fund reported 71 holdings worth US$8.56M as of Jul 31, 2026 (Form N-PORT)

As of Jul 31, 2026 · Filed Sep 25, 2026

Lord Abbett Health Care Fund reported 71 holdings worth US$8.56M as of Jul 31, 2026. Largest: Eli Lilly And Company, Unitedhealth Group Incorporated and Johnson & Johnson. Filed Sep 25, 2026 (Form N-PORT).

Holdings
71
Value as reported
US$8.56M

The filing in full

CompanySharesValue as reported% of portfolio
Eli Lilly And Company775US$890K10.4%
Unitedhealth Group Incorporated1,115US$462K5.4%
Johnson & Johnson1,656US$425K5.0%
Novartis Ag2,292US$358K4.2%
Natera, Inc.1,151US$308K3.6%
Gilead Sciences, Inc.2,323US$302K3.5%
Cvs Health Corporation2,734US$286K3.3%
Guardant Health, Inc.1,381US$224K2.6%
Galderma Group Ag1,023US$223K2.6%
Thermo Fisher Scientific Inc345US$198K2.3%
Cogent Biosciences, Inc.4,983US$194K2.3%
Vertex Pharmaceuticals Incorporated402US$192K2.2%
10x Genomics, Inc.3,910US$185K2.2%
Beone Medicines Ltd. Class A563US$176K2.1%
Ascendis Pharma A/s698US$170K2.0%
Astrazeneca Plc992US$169K2.0%
Madrigal Pharmaceuticals, Inc.350US$164K1.9%
Bridgebio Pharma, Inc.1,969US$158K1.8%
Edwards Lifesciences Corporation1,775US$153K1.8%
Revolution Medicines, Inc.764US$143K1.7%
Arrowhead Pharmaceuticals, Inc.1,538US$130K1.5%
Protagonist Therapeutics, Inc.905US$124K1.4%
Dianthus Therapeutics, Inc.1,152US$123K1.4%
Adaptive Biotechnologies Corporation5,407US$122K1.4%
Illumina, Inc.594US$122K1.4%
Argenx Se131US$122K1.4%
United Therapeutics Corporation234US$121K1.4%
Ucb S.a.450US$116K1.3%
Mirum Pharmaceuticals, Inc.1,087US$115K1.3%
Glaukos Corporation671US$112K1.3%
Ptc Therapeutics, Inc.1,632US$111K1.3%
Teva Pharmaceutical Industries Limited2,957US$104K1.2%
Otsuka Holdings Co., Ltd.1,448US$100K1.2%
Intuitive Surgical, Inc.259US$91,5121.1%
Roivant Sciences Ltd.2,674US$90,6751.1%
Cg Oncology, Inc.1,223US$87,0651.0%
Hinge Health, Inc.1,123US$83,8990.98%
Enliven Therapeutics, Inc.1,478US$81,0090.95%
Oruka Therapeutics, Inc.828US$79,9100.93%
Celcuity Inc.896US$77,3960.90%
Encompass Health Corporation677US$75,1940.88%
West Pharmaceutical Services, Inc.204US$69,5560.81%
Newamsterdam Pharma Company N.v.2,496US$69,3640.81%
Forte Biosciences, Inc.881US$67,4850.79%
Definium Therapeutics, Inc.1,459US$63,4960.74%
Alumis Inc.2,183US$61,6700.72%
Stryker Corporation186US$60,5800.71%
Praxis Precision Medicines, Inc.193US$59,4110.69%
Tango Therapeutics, Inc.2,000US$54,3600.63%
Samsung Biologics Co., Ltd.51US$52,4710.61%
Idexx Laboratories, Inc.89US$49,7570.58%
Heartflow, Inc.1,602US$40,4180.47%
Dbv Technologies Sa2,973US$40,1360.47%
Scholar Rock Holding Corporation822US$38,8760.45%
Jade Biosciences, Inc.1,934US$38,1970.45%
Kymera Therapeutics, Inc.362US$37,4310.44%
Brightspring Health Services, Inc.605US$36,1250.42%
Repligen Corporation0US$00.00%
Radnet, Inc.0US$00.00%
Transmedics Group, Inc.0US$00.00%
Insmed Incorporated0US$00.00%
Cencora, Inc.0US$00.00%
Nuvalent, Inc.0US$00.00%
Nektar Therapeutics0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
Abivax Sa0US$00.00%
Rhythm Pharmaceuticals, Inc.0US$00.00%
Genedx Holdings Corp.0US$00.00%
Mineralys Therapeutics, Inc.0US$00.00%
Tarsus Pharmaceuticals, Inc.0US$00.00%
Oric Pharmaceuticals, Inc.0US$00.00%

Source

View original at SEC

Related